Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

The first Symbicort generic, simply referred to as budesonide/formoterol inhaler, was approved by the Food and Drug ...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper ... with a fast action, in a single inhaler. A Viatris spokesperson said: "Viatris obviously ...

including a generic version of Symbicort and one other undisclosed inhalation product. Symbicort is an asthma and COPD medication with over $3 billion in annual sales, presenting a major market ...